Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (105,628)	$ (8,798)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	21,719	20,026
Amortization of intangible assets	26,460	19,734
Reduction in carrying amount of right-of-use asset	12,469
Provision for doubtful accounts	1,267	1,369
Share-based compensation	26,935	24,339
Deferred income taxes	1,293	(6,030)
Non-cash restructuring and impairment charges	7,622
Non-cash interest expense	3,070	2,308
Other	(395)	15
Changes in operating assets and liabilities, net of acquisitions
Accounts receivable	88,688	69,328
Inventories	16,373	6,222
Prepaid expenses and other assets	438	(6,993)
Accounts payable	(21,530)	(26,348)
Accrued compensation and benefits	(24,009)	(17,502)
Operating lease liabilities	(13,222)
Deferred revenue	43	13,197
Other current and long-term liabilities	(14,532)	(11,365)
Net cash provided by operating activities	27,061	79,502
Cash flows from investing activities:
Capital expenditures	(12,630)	(16,181)
Business acquisitions, net of cash acquired	(219,458)
Maturities and sales of investments	45,249	727
Net cash used in investing activities	(186,839)	(15,454)
Cash flows from financing activities:
Borrowings under Revolving Facility	55,000
Borrowings under Term Loan	199,500
Repayments of debt	(29,767)	(17,403)
Loan fees on borrowings	(10,514)	(545)
Repurchase of common stock	(30,000)	(15,000)
Proceeds from issuance of common stock, net of tax withholding	9,491	13,044
Payment of contingent consideration obligations	(3,448)	(5,274)
Deferred payments on an acquisition	(3,000)	(3,000)
Net cash provided by (used in) financing activities	187,262	(28,178)
Foreign currency effect on cash	(741)	(196)
Net increase in cash	26,743	35,674
Cash at beginning of period	169,607	121,139
Cash at end of period	$ 196,350	$ 156,813